Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

AMG-529

Catalog No. T9901A-968 Copy Product Info
🥰Excellent
AMG-529 is a humanized monoclonal antibody targeting the asialoglycoprotein receptor 1 (ASGR1). Primarily expressed on hepatocytes, ASGR1 mediates the endocytosis and degradation of circulating asialoglycoproteins. AMG-529 functions by specifically binding to ASGR1 and blocking ligand interactions, thereby inhibiting receptor function. Clinical studies demonstrate that ASGR1 inhibition leads to a dose-dependent elevation in serum alkaline phosphatase (ALP) levels, which serves as a circulating biomarker for suppressed ASGR1 activity. This antibody is utilized in research concerning lipid metabolism regulation and cardiovascular protection mechanisms.

AMG-529

Copy Product Info
🥰Excellent
Catalog No. T9901A-968

AMG-529 is a humanized monoclonal antibody targeting the asialoglycoprotein receptor 1 (ASGR1). Primarily expressed on hepatocytes, ASGR1 mediates the endocytosis and degradation of circulating asialoglycoproteins. AMG-529 functions by specifically binding to ASGR1 and blocking ligand interactions, thereby inhibiting receptor function. Clinical studies demonstrate that ASGR1 inhibition leads to a dose-dependent elevation in serum alkaline phosphatase (ALP) levels, which serves as a circulating biomarker for suppressed ASGR1 activity. This antibody is utilized in research concerning lipid metabolism regulation and cardiovascular protection mechanisms.

AMG-529
Pack SizePriceUSA StockGlobal StockQuantity
1 mgInquiryInquiryInquiry
5 mgInquiryInquiryInquiry
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
AMG-529 is a humanized monoclonal antibody targeting the asialoglycoprotein receptor 1 (ASGR1). Primarily expressed on hepatocytes, ASGR1 mediates the endocytosis and degradation of circulating asialoglycoproteins. AMG-529 functions by specifically binding to ASGR1 and blocking ligand interactions, thereby inhibiting receptor function. Clinical studies demonstrate that ASGR1 inhibition leads to a dose-dependent elevation in serum alkaline phosphatase (ALP) levels, which serves as a circulating biomarker for suppressed ASGR1 activity. This antibody is utilized in research concerning lipid metabolism regulation and cardiovascular protection mechanisms.
In vitro
In biochemical assays, AMG-529 demonstrates high affinity for the extracellular domain of human ASGR1. In cell-based models, the antibody effectively blocks the binding and subsequent internalization of asialoglycoprotein ligands, preventing receptor-mediated endocytosis [1].
Reactivity
Human
Application
FACS
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Uniprot ID
TargetASGR1
Chemical Properties
Antibody Information
IsotypeIgG1
Storage & Solubility Information
Storagestore at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: buy AMG-529 | purchase AMG-529 | AMG-529 cost | order AMG-529 | AMG-529 in vitro